Radiosurgical Planning

Slides:



Advertisements
Similar presentations
What is the treatment?. Treatment of Retinoblastoma Choosing the most appropriate cancer treatment is a decision that ideally involves the patient, family,
Advertisements

What is the treatment?. Treatment of Retinoblastoma Choosing the most appropriate cancer treatment is a decision that ideally involves the patient, family,
Skeletons and gamma ray radiosurgery The Mathematics of Shapes.
LCSC - 01 Monte Carlo Simulation of Radiation Transport, for Stereotactic Radio Surgery Per Kjäll Elekta Instrument AB
Copyright ©2008 Accuray, Incorporated. All rights reserved E CyberKnife ® Robotic Radiosurgery System Radiosurgery System Comparisons.
 What Is Cancer? The word cancer actually refers to many diseases, not one. In fact, there are more than 100 types of diseases known collectively as.
Radiotherapy Planning Stephen C. Billups University of Colorado at Denver
An Efficient Motion Planner Based on Random Sampling Jean-Claude Latombe Computer Science Department Stanford University.
CyberKnife Truly a Technological Advancement Mohammad AlBader.
CS 326 A: Motion Planning Radiosurgical Planning.
CS 326 A: Motion Planning Radiosurgical Planning.
Radiosurgical Planning. Radiosurgery Tumor = bad Brain = good Critical structures = good and sensitive Minimally invasive procedure that uses an intense,
Stereotactic Radiosurgery Jimmy Johannes Physics 335 – Spring 2004 Final Presentation
Motion Planning in Stereotaxic Radiosurgery A. Schweikard, J.R. Adler, and J.C. Latombe Presented by Vijay Pradeep.
Introduction to Radiation Therapy
Stereotactic RadiologyStereotactic Radiology By: Jeremy Lishner.
Surgery Surgery is the initial therapy for nearly all patients with brain tumors and can cure most benign tumors, including meningiomas Goal : to remove.
Stereotactic Body Radiation Therapy (SBRT): The optimal indication for operable tumors in inoperable patients D.Katsochi 1, S.Kosmidis 1, A.Fotopoulou.
At the position d max of maximum energy loss of radiation, the number of secondary ionizations products peaks which in turn maximizes the dose at that.
Design and Scheduling of Proton Therapy Treatment Centers Stuart Price, University of Maryland Bruce Golden, University of Maryland Edward Wasil, American.
Radiotherapy for Kidney cancer
Radiation therapy is based on the exposure of malign tumor cells to significant but well localized doses of radiation to destroy the tumor cells. The.
Gamma Knife Surgery and Region Covering Aaron Epel.
Optimization of Gamma Knife Radiosurgery Michael Ferris, Jin-Ho Lim University of Wisconsin, Computer Sciences David Shepard University of Maryland School.
Simulating Potential Layouts for a Proton Therapy Treatment Center Stuart Price-University of Maryland Bruce Golden- University of Maryland Edward Wasil-
 The CyberKnife is a type radiation emitting machine used for the treatment of cancer. It emits radiation in high doses to millimeter precision. The.
Mariah Cordie and Deb Norrell. What is CyberKnife?  World’s first and only robotic radiosurgery system designed to treat tumors throughout the body non-
Data Mining to Aid Beam Angle Selection for IMRT Stuart Price-University of Maryland Bruce Golden- University of Maryland Edward Wasil- American University.
TALKING TO THE PATIENT AND FAMILY!. While talking to the patient and their family… *Sit down and make eye contact with the patient and their family.
1 Overview of Gamma Knife ® Surgery Dr. Sandra Vermeulen, M.D. Swedish Cancer Institute Northwest Hospital Gamma Knife Center Seattle, Washington Learn.
Using Radiation in Medicine. There are 3 main uses of radiation in medicine: Treatment Diagnosis Sterilization.
Learn More At: CyberKnife Radiosurgery in the Treatment of Early and Advanced (Oligo-Metastases) Breast Cancer Sandra Vermeulen,
Reimbursement of radiotherapy in Belgium The old reimbursement system The new system The desired system Nicolas Jansen Liege University Hospital.
Medical Accelerator F. Foppiano, M.G. Pia, M. Piergentili
A Comparison Between Two Leading Stereotactic Platforms in the Treatment of Multiple Metastases Sandra Vermeulen MD, James Raisis.
Introduction to Radiation Therapy
Athula D. A. Gunawardena, Michael C. Ferris and Robert R. Meyer University of Wisconsin-Whitewater, and University of Wisconsin-Madison.
Understanding Radiation Therapy
 Multidisciplinary Effort › Surgery › Radiation › Systemic Rx (chemo, “drugs”)
THE IMPLEMENTATION OF ABLATIVE HYPOFRACTIONATED RADIOTHERAPY FOR STEREOTACTIC TREATMENTS IN THE BRAIN AND BODY: OBSERVATIONS ON EFFICACY AND TOXICITY IN.
Rigid Needles, Steerable Needles, and Optimal Beam Algorithms Ovidiu Daescu Bio-Medical Computing Laboratory Department of Computer Science University.
Presentation By: Jonathan, Marty and Kiran
Treatment Chart Record of patients radiation therapy history. Must contain: History and diagnosis Rationale for treatment Treatment plan Consent Documentation.
Who are Oncologists? The diagnosis, treatment & prevention of cancer is termed as Oncology and Oncologists are doctors who specialise in the treatment.
Martin J Murphy PhD Department of Radiation Oncology
Understanding Radiation Therapy Lecturer Radiological Science
cyberknife®: can we cure pancreatic cancer?
Kasey Etreni BSc., MRT(T), RTT, CTIC
Extending intracranial treatment options with Leksell Gamma Knife® Icon™ Key Statements from Customer Perspective by University Medical Centre Mannheim.
Electron Beam Therapy.
Leksell Gamma Knife® Icon™
Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trial  Richard I Whyte, MD, Richard Crownover, MD, PhD, Martin J Murphy, PhD,
Courtesy from Dr. McNutt
Learning About PET/CT Scans:
Gamma Knife Radiosurgery
Fig. 4. Percentage of passing rate between clinical and 544 plans.
Reducing Treatment Time and MUs by using Dynamic Conformal Arc Therapy for SBRT Breath-Hold Patients Timothy Miller, Sebastian Nunez Albermann, Besil Raju,
Doc.Ing. Josef Novotný,CSc
Optimization of Gamma Knife Radiosurgery
Radiosurgical Management of Brain Metastases
Motion Planning in Stereotaxic Radiosurgery
Clinical Radiation Oncology NMT232 L 10
Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trial  Richard I Whyte, MD, Richard Crownover, MD, PhD, Martin J Murphy, PhD,
Innovations in the Radiotherapy of Non–Small Cell Lung Cancer
Jay Douglas Department of Radiation Oncology
Hot and cold spots are common problems associated with planning:
STOCKPORT TOGETHER: CONSULTATION MENTAL HEALTH CARERS GROUP
Understanding Radiation Therapy
Principles of Radiation Therapy
Presentation transcript:

Radiosurgical Planning

Radiosurgery Minimally invasive procedure that uses an intense, focused beam of radiation as an ablative surgical instrument to destroy tumors Tumor = bad Critical structures = good and sensitive Brain = good

The Radiosurgery Problem Dose from multiple beams is additive

Treatment Planning for Radiosurgery Determine a set of beam configurations that will destroy a tumor by cross-firing at it Constraints: Desired dose distribution Physical properties of the radiation beam Constraints of the device delivering the radiation Duration/fractionation of treatment Critical Tumor I put the first sentence in light yellow and added fractionation in last item

After 16 weeks Prior After 10 weeks

Conventional Radiosurgical Systems Isocenter-based treatments Stereotactic frame required Gamma Knife LINAC System Luxton et al., 1993 Winston and Lutz, 1988

Isocenter-Based Treatments All beams converge at the isocenter The resulting region of high dose is spherical Nonspherically shaped tumors are approximated by multiple spheres “Cold Spots” where coverage is poor “Hot Spots” where the spheres overlap Over-irradiation of healthy tissue

Stereotactic Frame for Localization Painful Fractionation of treatments is difficult Treatment of extracranial tumors is impossible

The CyberKnife linear accelerator robotic gantry X-Ray cameras

CyberKnife (Accuray) http://accuray.com/

Treatment Planning Becomes More Difficult Much larger solution space Beam configuration space has greater dimensionality Number of beams can be much larger More complex interactions between beams Path planning Avoid collisions Do not obstruct X-ray cameras  Automatic planning required (CARABEAMER) I put an arrow for the last bullet

Inputs to CARABEAMER (1) Regions of Interest: Surgeon delineates the I changed title Surgeon delineates the regions of interest CARABEAMER creates 3D regions

Inputs to CARABEAMER (2) Dose Constraints: (3) Maximum number of beams Dose to tumor Critical Tumor Falloff of dose around tumor Dose to critical structure Falloff of dose in critical structure

Basic Problem Solved by CARABEAMER Given: Spatial arrangement of regions of interest Dose constraints for each region: a  D  b Max number of beams allowed: N (~100-400) Find: N beam configurations (or less) that generate dose distribution that meets the constraints. I changed the title

Beam Configuration Position and orientation of the radiation beam Amount of radiation or beam weight Collimator diameter x y z   (x, y) I removed the bullet on the last line  Find 6N parameters that satisfy the constraints

CARABEAMER’s Approach Initial Sampling: Generate many (> N) beams at random, with each beam having a reasonable probability of being part of the solution. Weighting: Use linear programming to test whether the beams can produce a dose distribution that satisfies the input constraints. Iterative Re-Sampling: Eliminate beams with small weights and re-sample more beams around promising beams. Iterative Beam Reduction: Progressively reduce the number of beams in the solution.

Initial Beam Sampling Generate even distribution of target points on the surface of the tumor Define beams at random orientations through these points

Deterministic Beam Selection is Less Robust

Curvature Bias Place more target points in regions of high curvature

Dose Distribution Before Beam Weighting 50% Isodose Surface 80% Isodose Surface

CARABEAMER’s Approach Initial Sampling: Generate many (> N) beams at random, with each beam having a reasonable probability of being part of the solution. Weighting: Use linear programming to test whether the beams can produce a dose distribution that satisfies the input constraints. Iterative Re-Sampling: Eliminate beams with small weights and re-sample more beams around promising beams. Iterative Beam Reduction: Progressively reduce the number of beams in the solution.

Beam Weighting Construct geometric arrangement of regions formed by the beams and the tissue structures T C B1 B2 B3 B4 Assign constraints to each cell of the arrangement: Tumor constraints Critical constraints I suppressed the last bullet. Too much a detail

Linear Programming Problem • 2000  Tumor  2200 2000  B2 + B4  2200 2000  B4  2200 2000  B3 + B4  2200 2000  B3  2200 2000  B1 + B3 + B4  2200 2000  B1 + B4  2200 2000  B1 + B2 + B4  2200 2000  B1  2200 2000  B1 + B2  2200 T C B1 B2 B3 B4 • 0  Critical  500 0  B2  500

Results of Beam Weighting Before Weighting After Weighting 50% Isodose surfaces 80% Isodose surfaces

CARABEAMER’s Approach Initial Sampling: Generate many (> N) beams at random, with each beam having a reasonable probability of being part of the solution. Weighting: Use linear programming to test whether the beams can produce a dose distribution that satisfies the input constraints. Iterative Re-Sampling: Eliminate beams with small weights and re-sample more beams around promising beams. Iterative Beam Reduction: Progressively reduce the number of beams in the solution.

CARABEAMER’s Approach Initial Sampling: Generate many (> N) beams at random, with each beam having a reasonable probability of being part of the solution. Weighting: Use linear programming to test whether the beams can produce a dose distribution that satisfies the input constraints. Iterative Re-Sampling: Eliminate beams with small weights and re-sample more beams around promising beams. Iterative Beam Reduction: Progressively reduce the number of beams in the solution.

Plan Review Calculate resulting dose distribution Radiation oncologist reviews If satisfactory, treatment can be delivered If not... Add new constraints Adjust existing constraints

Treatment Planning: Extensions Simple path planning and collision avoidance Automatic collimator selection Critical Tumor

Evaluation on Sample Case Linac plan 80% Isodose surface CARABEAMER’s plan 80% Isodose surface

Another Sample Case 50% Isodose Surface 80% Isodose Surface LINAC plan CARABEAMER’s plan

Evaluation on Synthetic Data 2000  DT  2400, DC  500 n = 500 n = 250 n = 100 Constraint Iteration 10 random seeds X 2000  DT  2200, DC  500 X X X Beam Iteration 2000  DT  2100, DC  500

Dosimetry Results Case #1 Case #2 Case #3 Case #4 80% Isodose Curve

Average Run Times Case 1 Beam Constr Case 2 Beam Constr Case 3 2000-2400 n = 500 n = 250 n = 100 2000-2200 2000-2100 :20 :35 :32 :29 :43 :01:34 :01:28 :02:21 :41 :40 :51 :50 :59 :01:02 :01:41 :01:31 :02:38 :03:30 :03:32 :04:28 :05:50 :08:53 :48:54 :40:49 1:57:25 :05:23 :05:33 :07:19 :08:37 :08:42 :10:43 :27:39 :24:43 1:02:27 :04:36 :04:11 :05:03 :23:51 :24:44 :33:02 3:26:33 3:22:15 7:44:57 :06:45 :07:19 :07:06 :13:05 :12:16 :21:06 1:03:06 1:07:12 5:06:29 3:06:12 3:09:19 3:35:28 25:38:36 27:55:18 53:58:56 1:40:55 1:44:18 1:41:19 6:33:02 7:11:01 176:25:02 44:11:04 84:21:27

Evaluation on Prostate Case 50% Isodose surface 70% Isodose surface

Cyberknife Systems News Service /Press Releases                                Contact Stanford Report News Service /Press Releases                                                                                                                  Stanford Report, July 25, 2001 Patients gather to praise minimally invasive technique used in treating tumors By MICHELLE BRANDT When Jeanie Schmidt, a critical care nurse from Foster City, lost hearing in her left ear and experienced numbing in her face, she prayed that her first instincts were off. “I said to the doctor, `I think I have an acoustic neuroma (a brain tumor), but I'm hoping I'm wrong. Tell me it's wax, tell me it's anything,'” Schmidt recalled. It wasn't wax, however, and Schmidt – who wound up in the Stanford Hospital emergency room when her symptoms worsened – was quickly forced to make a decision regarding treatment for her tumor. On July 13, Schmidt found herself back at Stanford – but this time with a group of patients who were treated with the same minimally invasive treatment that Schmidt ultimately chose: the CyberKnife. She was one of 40 former patients who met with Stanford faculty and staff to discuss their experiences with the CyberKnife – a radiosurgery system designed at Stanford by John Adler Jr., MD, in 1994 for performing neurosurgeries without incisions. “I wanted the chance to thank everyone again and to share experiences with other patients,” said Schmidt, who had the procedure on June 20 and will have an MRI in six months to determine its effectiveness. “I feel really lucky that I came along when this technology was around.” The CyberKnife is the newest member of the radiosurgery family. Like its ancestor, the 33-year-old Gamma Knife, the CyberKnife uses 3-D computer targeting to deliver a single, large dose of radiation to the tumor in an outpatient setting. But unlike the Gamma Knife – which requires patients to wear an external frame to keep their head completely immobile during the procedure – the CyberKnife can make real-time adjustments to body movements so that patients aren't required to wear the bulky, uncomfortable head gear. The procedure provides patients an alternative to both difficult, risky surgery and conventional radiation therapy, in which small doses of radiation are delivered each day to a large area. The procedure is used to treat a variety of conditions – including several that can't be treated by any other procedure – but is most commonly used for metastases (the most common type of brain tumor in adults), meningomas (tumors that develop from the membranes that cover the brain), and acoustic neuromas. Since January 1999, more than 335 patients have been treated at Stanford with the CyberKnife.

May 2010 Number of CK installations: 182 Installation locations: 24 countries http://www.accuray.com/CyberKnifeCenters/index.aspx Patients treated to date: Over 100,000? (40,000 in May 2008) Indications: Brain, spine, lung, prostate, liver, pancreas (most common)

After 2 months Meningioma affecting vision 208 beam positions. The patient was treated with 5 fractions over 5 days at 40 minutes per fraction.

Prostate Spine Lung Pancreas Kidney http://accuray.com/